Drugs / IDP-73152
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01904318 | Jul → Dec 2013 | — | IlDong Pharmaceutical Co Ltd | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2013-12-04 | IlDong Pharmaceutical Co Ltd | Regulatory 슈퍼박테리아 대항 신약후보물질 일본특허 획득 ildong.com ↗
일동제약(대표 이정치)이 ‘신규 펩티드 데포르밀라제 저해제 화합물(IDP-73152) 및 그 제조방법’과 관련한 일본 특허를 획득했다고 4일 밝혔다. |
| 2012-06-20 | IlDong Pharmaceutical Co Ltd | Regulatory 슈퍼박테리아 대항 항생신약 개발 박차 ildong.com ↗ |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2013-12-04 | IlDong Pharmaceutical Co Ltd | 슈퍼박테리아 대항 신약후보물질 일본특허 획득 ildong.com ↗ |
| 2012-06-20 | IlDong Pharmaceutical Co Ltd | 슈퍼박테리아 대항 항생신약 개발 박차 ildong.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDP-73152 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01904318 ↗ |
| Route | Oral | “after oral administration” NCT01904318 ↗ |